Docosahexaenoic acid nanoencapsulated with anti-PECAM-1 as co-therapy for atherosclerosis regression (2021)
- Authors:
- USP affiliated authors: POHLMANN, ADRIANA RAFFIN - FCF ; FARSKY, SANDRA HELENA POLISELLI - FCF ; UCHIYAMA, MAYARA KLIMUK - IQ ; ARAKI, KOITI - IQ ; ERGER, INAR CASTRO - FCF ; SANDRI, SILVANA - FCF ; LEÃO, MATHEUS DE CASTRO - FCF
- Unidades: FCF; IQ
- DOI: 10.1016/j.ejpb.2020.12.016
- Subjects: ARTERIOSCLEROSE; ESTRESSE OXIDATIVO; ÁCIDOS GRAXOS OMEGA 3; NANOTECNOLOGIA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: European Journal of Pharmaceutics and Biopharmaceutics
- ISSN: 0939-6411
- Volume/Número/Paginação/Ano: v. 159, p. 99–107, 2021
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
LEÃO, Matheus de Castro et al. Docosahexaenoic acid nanoencapsulated with anti-PECAM-1 as co-therapy for atherosclerosis regression. European Journal of Pharmaceutics and Biopharmaceutics, v. 159, p. 99–107, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2020.12.016. Acesso em: 06 fev. 2026. -
APA
Leão, M. de C., Pohlmann, A. R., Alves, A. de C. S., Farsky, S. H. P., Uchiyama, M. K., Araki, K., et al. (2021). Docosahexaenoic acid nanoencapsulated with anti-PECAM-1 as co-therapy for atherosclerosis regression. European Journal of Pharmaceutics and Biopharmaceutics, 159, 99–107. doi:10.1016/j.ejpb.2020.12.016 -
NLM
Leão M de C, Pohlmann AR, Alves A de CS, Farsky SHP, Uchiyama MK, Araki K, Sandri S, Guterres SS, Castro IA de. Docosahexaenoic acid nanoencapsulated with anti-PECAM-1 as co-therapy for atherosclerosis regression [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2021 ; 159 99–107.[citado 2026 fev. 06 ] Available from: https://doi.org/10.1016/j.ejpb.2020.12.016 -
Vancouver
Leão M de C, Pohlmann AR, Alves A de CS, Farsky SHP, Uchiyama MK, Araki K, Sandri S, Guterres SS, Castro IA de. Docosahexaenoic acid nanoencapsulated with anti-PECAM-1 as co-therapy for atherosclerosis regression [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2021 ; 159 99–107.[citado 2026 fev. 06 ] Available from: https://doi.org/10.1016/j.ejpb.2020.12.016 - Direct effects of poly(ε-caprolactone) lipid-core nanocapsules on human immune cells
- Cytotoxicity and effectiveness in macrophage polarization of Annexin A1-surface-functionalized metal-complex multi-wall lipid core nanocapsule
- Investigação dos efeitos citotóxicos e mecanismos de endocitose de nanopartículas magnéticas de óxido de ferro (spion) em endotélio vascular
- Toxicity evaluation of docosahexaenoic acid nanoencapsulated with anti-PECAM-1
- Imunotoxicologia
- Cisplatin treatment modulates Annexin A1 and inhibitor of differentiation to DNA 1 expression in cervical cancer cells
- Annexin A1/Formyl peptide receptor pathway controls uterine receptivity to the blastocyst
- Development of Annexin A1-surface-functionalized metal-complex multi-wall lipid core nanocapsules and effectiveness on experimental colitis
- Docosahexaenoic fatty acid nanoencapsulated with Anti-PECAM-1 as strategy to increase atherosclerotic plaque stability
- In vivo evaluation of toxicity and anti-inflammatory activity of iron oxide nanoparticles conjugated with ibuprofen
Informações sobre o DOI: 10.1016/j.ejpb.2020.12.016 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
